Merck & Co. MRK Equity Securities Without Readily Determinable Fair Value

Equity Securities Without Readily Determinable Fair Value at other companies

Uber TechnologiesUBER

$3.07B+113%

AirbnbABNB

$115M—

JPMorgan ChaseJPM

$1.6B+6.7%

Merck & Co.MRK

$172M+31.3%

CitigroupC

$22M-43.6%

SeaboardSEB

$166M—

FAQ

What is Merck & Co.'s equity securities without readily determinable fair value?

Merck & Co. (MRK) reported equity securities without readily determinable fair value of $172M in Q2 2026.

How has Merck & Co.'s equity securities without readily determinable fair value changed year-over-year?

Merck & Co.'s equity securities without readily determinable fair value increased by 31.3% year-over-year, from $131M to $172M.

What is the long-term trend for Merck & Co.'s equity securities without readily determinable fair value?

Over 5 years (2020 to 2025), Merck & Co.'s equity securities without readily determinable fair value has grown at a 47.2% compound annual growth rate (CAGR), from $24M to $166M.

What does equity securities without readily determinable fair value mean?

This represents the carrying amount of equity investments for which a readily determinable market price is not available, often including private equity or venture capital holdings. Because these assets lack a public market, they are measured using cost-based methods adjusted for observable price changes. This metric highlights the company's exposure to private or illiquid market investments.